Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127277271 | 12727727 | 1 | I | 20160829 | 20160909 | 20160909 | EXP | FR-TEVA-690422ISR | TEVA | SASSIER M, PEYRO-SAINT-PAUL L, CLARISSE B, LECONTE A, COQUEREL A, ALEXANDRE J, ET AL. CHEMOTHERAPY (PLATINUM AND PEMETREXED) IN COMBINATION WITH ERLOTINIB IN NON-SMALL CELL LUNG CANCER INDUCES MAJOR GASTROINTESTINAL TOXICITY: TWO CASE REPORTS FROM THE FLARE/GFPC 03-2013 STUDY. J-CLIN-PHARM-THER 2016;41(4):447-448. | 56.00 | YR | F | Y | 0.00000 | 20160909 | PH | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127277271 | 12727727 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Unknown | 90MG | U | 74656 | |||||||||
| 127277271 | 12727727 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 77269 | ||||||||||
| 127277271 | 12727727 | 3 | I | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | U | 72124 | ||||||||||
| 127277271 | 12727727 | 4 | I | erlotinib | ERLOTINIB | 1 | Unknown | 150MG/DAY | U | 0 | |||||||||
| 127277271 | 12727727 | 5 | I | pemetrexed | PEMETREXED | 1 | Unknown | 600MG | U | 0 | |||||||||
| 127277271 | 12727727 | 6 | I | APREPITANT. | APREPITANT | 1 | Unknown | U | 0 | ||||||||||
| 127277271 | 12727727 | 7 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | ||||||||||
| 127277271 | 12727727 | 8 | C | ondansetron | ONDANSETRON | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127277271 | 12727727 | 1 | Non-small cell lung cancer |
| 127277271 | 12727727 | 3 | Hypertension |
| 127277271 | 12727727 | 4 | Non-small cell lung cancer |
| 127277271 | 12727727 | 5 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127277271 | 12727727 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127277271 | 12727727 | Asthenia | |
| 127277271 | 12727727 | Diarrhoea | |
| 127277271 | 12727727 | Drug interaction | |
| 127277271 | 12727727 | Nausea | |
| 127277271 | 12727727 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127277271 | 12727727 | 1 | 20140806 | 0 | ||
| 127277271 | 12727727 | 4 | 201402 | 0 | ||
| 127277271 | 12727727 | 5 | 20140806 | 0 |